Is Marchex, Inc. overvalued or undervalued?

As of 5 May 2016, the valuation grade for Marchex, Inc. has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently considered overvalued based on its negative earnings and poor return metrics. Key ratios include a Price to Book Value of 2.69, an EV to EBIT of -14.99, and an EV to EBITDA of -26.42, all of which reflect the company's struggles in generating positive cash flows and profitability.
In comparison to its peers, Marchex, Inc. shows a stark contrast to QuinStreet, Inc., which has a P/E ratio of 357.48, and Thryv Holdings, Inc., with a P/E of 38.55, both indicating more favorable valuations in their respective contexts. The negative returns on capital employed (ROCE) of -22.94% and return on equity (ROE) of -17.46% further underscore the challenges faced by Marchex. Despite its recent stock performance outpacing the S&P 500, the overall financial health suggests that Marchex remains overvalued in the current market environment.